Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

November 08, 2018

Letter
Role of linoleic acid in autoimmune disorders: a Mendelian randomisation study

Jie V Zhao, C Mary Schooling

doi: 10.1136/annrheumdis-2018-214519
Correspondence
Metering the METEOR in methotrexate failure: is propensity score a falling star?
Free

Sakir Ahmed

doi: 10.1136/annrheumdis-2018-214612
Letter
Urate-lowering therapy (ULT) reduces non-episodic foot pain in patients who fail to meet ACR/EULAR 2015 gout classification criteria: an effect predicted by ultrasound and potential rationale for reclassification

Yousef Mohammed Alammari, Diana Gheta, Rachael Mary Flood, Gerard Boran, David J Kane, Ronan Hugh Mullan

doi: 10.1136/annrheumdis-2018-214305

November 02, 2018

Correspondence
Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment

Young Ho Lee

doi: 10.1136/annrheumdis-2018-214635
Correspondence response
Response to: ‘Knee osteoarthritis and bisphosphonates: Could BCP crystals be the missing link?’ by Murphy et al

Willem Lems

doi: 10.1136/annrheumdis-2018-214493
Letter
Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus Meeting

Johanna Mucke, Hans-Joachim Anders, Martin Aringer, Gamal Chehab, Rebecca Fischer-Betz, Falk Hiepe, Hanns-Martin Lorenz, Andreas Schwarting, Christof Specker, Reinhard E Voll, Matthias Schneider

doi: 10.1136/annrheumdis-2018-214160

October 29, 2018

Correspondence response
Response to: ‘Response to: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg

Eric F Morand, Teodora Trasieva, Anna Berglind, Gabor Illei, Raj Tummala

doi: 10.1136/annrheumdis-2018-214487
Correspondence
Response to: ‘Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al

David Isenberg

doi: 10.1136/annrheumdis-2018-214468

October 26, 2018

Correspondence response
Response to: ‘“MAINRITSAN2-the future”, with some doubts!’ by Chattopadhyay et al
Free

Pierre Charles, Loic Guillevin

doi: 10.1136/annrheumdis-2018-214516
Letter
Incidence of inflammatory polyarthritis in polymyalgia rheumatica: a population-based cohort study

Max Yates, Jalpa Kotecha, Richard A Watts, Robert Luben, Kay-Tee Khaw, Alexander J MacGregor

doi: 10.1136/annrheumdis-2018-214386

October 24, 2018

Letter
Autoinflammation due to homozygous S208 MEFV mutation

Ying Hong, Ariane S I Standing, Sira Nanthapisal, Neil Sebire, Stephen Jolles, Ebun Omoyinmi, Ruud HJ Verstegen, Paul A Brogan, Despina Eleftheriou

doi: 10.1136/annrheumdis-2018-214102

October 23, 2018

Correspondence response
Response to: ‘Clinical evidence guidelines in systemic lupus erythematosus: revaluation’ by Scheinberg
Free

Bernardo A Pons-Estel, Eloisa Bonfa, Enrique R Soriano, Mario Humberto Cardiel, Ariel Izcovich, Gloria Vázquez, Graciela S Alarcón

doi: 10.1136/annrheumdis-2018-214385
Correspondence response
Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez
Free

Dinesh Khanna, Angelika Jahreis, Celia J F Lin

doi: 10.1136/annrheumdis-2018-214477
Correspondence
Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect
Free

Vincent Germain, Marc Scherlinger, Thomas Barnetche, Thierry Schaeverbeke, On behalf of the Fédération Hospitalouniversitaire ACRONIM

doi: 10.1136/annrheumdis-2018-214374
Correspondence
Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series
Free

Javier Narváez, Judit LLuch, Juan José Alegre Sancho, Maria Molina-Molina, Joan Miquel Nolla, Ivan Castellví

doi: 10.1136/annrheumdis-2018-214449
Letter
Imaging and serum biomarkers in connective tissue disease–associated interstitial lung diseases: correlation between lung ultrasound B-lines and KL-6 levels

Yukai Wang, Shaoqi Chen, Zhangzhang Lin, Guangzhou Du, Jianqun Lin, Qisheng Lin, Huang Xiufeng, Guohong Zhang, Daniel E Furst, Luna Gargani, Marco Matucci-Cerinic

doi: 10.1136/annrheumdis-2018-214098
Correspondence
Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease
Free

Uta Kiltz, David Kiefer, Jürgen Braun, Eduardo Jorge Schiffrin, Charlotte Girard-Guyonvarc'h, Cem Gabay

doi: 10.1136/annrheumdis-2018-214496

October 18, 2018

Letter
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis

Silvia Bellando-Randone, Luca Tartarelli, Edorardo Cavigli, Lorenzo Tofani, Cosimo Bruni, Gemma Lepri, Jelena Blagojevic, Alberto Moggi-Pignone, Carina Mihai, Jerome Avouac, Alessandro Passeri, Maria Teresa De Cristofaro, Oliver Distler, Yannick Allanore, Serena Guiducci, Marco Matucci-Cerinic

doi: 10.1136/annrheumdis-2018-213376
Correspondence
Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease
Free

Young Ho Lee

doi: 10.1136/annrheumdis-2018-214494
Correspondence response
Response to: ‘Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease’ by Lee
Free

Laurence Fardet, Irene Petersen, Irwin Nazareth

doi: 10.1136/annrheumdis-2018-214515

October 12, 2018

Correspondence
‘MAINRITSAN2-the future’, with some doubts!
Free

Arghya Chattopadhyay, Nupoor Acharya, Debashish Mishra, Vikas Sharma, GSRSNK Naidu, Aman Sharma

doi: 10.1136/annrheumdis-2018-214486
Letter
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis

Mirko Manetti, Sara Pratesi, Eloisa Romano, Irene Rosa, Cosimo Bruni, Silvia Bellando-Randone, Serena Guiducci, Enrico Maggi, Lidia Ibba-Manneschi, Marco Matucci-Cerinic

doi: 10.1136/annrheumdis-2018-214240

October 09, 2018

Correspondence response
Response to: ‘Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis’ by Liebling et al
Free

Yoshikazu Nakaoka

doi: 10.1136/annrheumdis-2018-214239
Correspondence
Knee osteoarthritis and bisphosphonates: Could BCP crystals be the missing link?
Free

Claire-Louise M Murphy, Geraldine McCarthy

doi: 10.1136/annrheumdis-2018-214421

October 08, 2018

Editorial
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?

Stefan Siebert, Neal L Millar, Iain B McInnes

doi: 10.1136/annrheumdis-2018-213654

September 29, 2018

Correspondence response
Monocyte and macrophage phenotypes: a look beyond systemic sclerosis
Free

Maurizio Cutolo, Amelia Chiara Trombetta, Stefano Soldano

doi: 10.1136/annrheumdis-2018-214371
Correspondence
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Free

Alain Lescoat, Alice Ballerie, Stephane Jouneau, Olivier Fardel, Laurent Vernhet, Patrick Jego, Valérie Lecureur

doi: 10.1136/annrheumdis-2018-214333
Correspondence
Clinical evidence guidelines in systemic lupus erythematosus: revaluation
Free

Morton Scheinberg

doi: 10.1136/annrheumdis-2018-214357

September 21, 2018

Correspondence
Coffee consumption and gout: a Mendelian randomisation study
Free

Young Ho Lee

doi: 10.1136/annrheumdis-2018-214356
Correspondence
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis
Free

Julie Delyon, Florence Brunet-Possenti, Sarah Leonard-Louis, Dimitri Arangalage, Mathilde Baudet, Barouyr Baroudjian, Celeste Lebbe, Baptiste Hervier

doi: 10.1136/annrheumdis-2018-214336

September 07, 2018

Correspondence
Will SPAR be useful in the usual patients with scleroderma?
Free

Arghya Chattopadhyay, Varun Dhir, Shefali Sharma, Aman Sharma, Sanjay Jain

doi: 10.1136/annrheumdis-2018-214256

September 05, 2018

Correspondence response
Response to: ‘The revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment’ by Broeders et al
Free

Jan Damoiseaux

doi: 10.1136/annrheumdis-2018-214243
Correspondence
Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment
Free

Sylvia Broeders, Sylvie Goletti, Jean-Paul Tomasi, Carolien Bonroy, René-Louis Humbel, Laurence Lutteri, Sofie Schouwers, Lieve Van Hoovels, Martine Vercammen, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-214078

August 27, 2018

Correspondence
Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
Free

Emily J Liebling, Rosemary Peterson, Teresa Victoria, Jon M Burnham

doi: 10.1136/annrheumdis-2018-214191

August 20, 2018

Correspondence
Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis

Ricardo J O Ferreira, Mwidimi Ndosi, Maarten de Wit, Eduardo José Ferreira Santos, Cátia Duarte, Johannes W G Jacobs, Pedro M Machado, Désirée van der Heijde, Laure Gossec, Jose A P da Silva

doi: 10.1136/annrheumdis-2018-214199
Correspondence response
Response to: ’Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis' by Ferreira et al

Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214221

August 17, 2018

Correspondence response
Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al

Maya H Buch

doi: 10.1136/annrheumdis-2018-214153

August 14, 2018

Correspondence
Digital health in rheumatology

Vinod Ravindran, Suchitra Kataria

doi: 10.1136/annrheumdis-2018-214146

August 12, 2018

Correspondence response
Response to: ‘Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated’ by Moiseev et al

Liang Wu, Min Chen

doi: 10.1136/annrheumdis-2018-214145
Correspondence response
Response to: ‘Checkpoint inhibitors and arthritis: seeking balance between victories and defeats’ by Moura and Moura

Thierry Schaeverbeke, Marie Kostine

doi: 10.1136/annrheumdis-2018-213906

August 10, 2018

Correspondence response
Response to: ’Early identification of rheumatoid arthritis; the risk of overtreatment in perspective' by Landewé

Robert B M Landewé

doi: 10.1136/annrheumdis-2018-214172
Correspondence
Early identification of rheumatoid arthritis: the risk of overtreatment in perspective

Annette van der Helm-van Mil

doi: 10.1136/annrheumdis-2018-214156

July 30, 2018

Correspondence
Response to viewpoint ‘Defining refractory rheumatoid arthritis’ by Buch

Nadia MT Roodenrijs, Maria JH de Hair, Marlies C van der Goes, Johannes WG Jacobs

doi: 10.1136/annrheumdis-2018-214147
Correspondence
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated

Nikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, Sergey V Moiseev

doi: 10.1136/annrheumdis-2018-214095

July 27, 2018

Correspondence response
Response to: ‘Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors’ by Delyon et al

Marie Kostine, Thierry Schaeverbeke on behalf of the FHU-ACRONIM

doi: 10.1136/annrheumdis-2018-213895

July 21, 2018

Correspondence response
Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al

Wanlong Wu, Suzana Jordan, Oliver Distler

doi: 10.1136/annrheumdis-2018-213962

July 20, 2018

Correspondence
Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?

Gaetane Nocturne, Raphaele Seror, Xavier Mariette

doi: 10.1136/annrheumdis-2018-213979
Correspondence response
Response to: ‘Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?’ by Nocturne et al

Efstathia K Kapsogeorgou, Aristea Papageorgiou, Athanase D Protogerou, Michael Voulgarelis, Athanasios G Tzioufas

doi: 10.1136/annrheumdis-2018-214009

July 12, 2018

Correspondence response
Response to: ‘The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?’ by Wu et al

Lennart Jans, Isabelle De Kock, Nele Herregods, Koenraad L Verstraete, Filip E Van den Bosch, Philippe Carron, Edwin H Oei, Dirk Elewaut, Peggy Jacques

doi: 10.1136/annrheumdis-2018-213960
Correspondence
Use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?

Haijun Wu, Guangfeng Zhang, Xiaoyu Huang, Changhong Liang

doi: 10.1136/annrheumdis-2018-213892

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

November 08, 2018

November 02, 2018

October 29, 2018

October 26, 2018

October 24, 2018

October 23, 2018

October 18, 2018

October 12, 2018

October 09, 2018

October 08, 2018

September 29, 2018

September 21, 2018

September 07, 2018

September 05, 2018

August 27, 2018

August 20, 2018

August 17, 2018

August 14, 2018

August 12, 2018

August 10, 2018

July 30, 2018

July 27, 2018

July 21, 2018

July 20, 2018

July 12, 2018

Pages